國立虎尾科技大學 |

Translational research methods for diabetes, obesity and cardiometabolic drug development = a focus on early phase clinical studies /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Translational research methods for diabetes, obesity and cardiometabolic drug development/ edited by Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch.
Reminder of title:	a focus on early phase clinical studies /
other author:	Krentz, Andrew J.
Published:	London :Springer London : : 2015.,
Description:	xii, 312 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Drug development. -
Online resource:	http://dx.doi.org/10.1007/978-1-4471-4920-0
ISBN:	9781447149200 (electronic bk.)

Translational research methods for diabetes, obesity and cardiometabolic drug development = a focus on early phase clinical studies /
Translational research methods for diabetes, obesity and cardiometabolic drug developmenta focus on early phase clinical studies /[electronic resource] :edited by Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch. - London :Springer London :2015. - xii, 312 p. :ill., digital ;24 cm.

1. Review of physiology/pathophysiology -- 2. Methods for assessing insulin action in humans -- 3. Assessment of insulin secretion -- 4. Measurement of ectopic fat in liver and muscle using magnetic resonance spectroscopy -- 5. Isotopic tracers for the measurement of metabolic flux -- 6. Measuring food intake in clinical drug development -- 7. Measurement of energy expenditure -- 8. Assessment of body composition -- 9. Assessment of cardiovascular safety of new diabetes drugs.

This book aims to aid the selection of the most appropriate techniques for use in early phase (1 and 2) clinical studies of new drugs for diabetes, obesity, and related cardiometabolic disease. Clinical research methods for assessing the pharmacokinetics and pharmacodynamics of new diabetes drugs, e.g. the euglycaemic clamp technique, have become well-established in proof-of-mechanism studies; however, selection of the best techniques is by no means straightforward. This book will aid the understanding of the need for new pharmacotherapies for type 1 diabetes, type 2 diabetes, and obesity and the molecular targets of drugs currently in development. Emerging technologies including the omics disciplines are considered together with practical and ethical issues of early phase clinical trials in subjects with cardiometabolic disorders. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development will be of interest to biomedical scientists, pharmacologists, academics involved in metabolic research and clinicians practicing in these specialties.

ISBN: 9781447149200 (electronic bk.)

Standard No.: 10.1007/978-1-4471-4920-0doiSubjects--Topical Terms:

581824
Drug development.

LC Class. No.: RM301.25

Dewey Class. No.: 615.19

Translational research methods for diabetes, obesity and cardiometabolic drug development = a focus on early phase clinical studies /
LDR:02606nam a2200313 a 4500 001 835309
003 DE-He213
005 20150722094808.0
006 m d
007 cr nn 008maaau
008 160421s2015 enk s 0 eng d
020 $a 9781447149200 (electronic bk.)
020 $a 9781447149194 (paper)
024 7 $a 10.1007/978-1-4471-4920-0 $2 doi
035 $a 978-1-4471-4920-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25
072 7 $a MB $2 bicssc
072 7 $a MED000000 $2 bisacsh
082 0 4 $a 615.19 $2 23
090 $a RM301.25 $b .T772 2015
245 0 0 $a Translational research methods for diabetes, obesity and cardiometabolic drug development $h [electronic resource] : $b a focus on early phase clinical studies / $c edited by Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch.
260 $a London : $c 2015. $b Springer London : $b Imprint: Springer,
300 $a xii, 312 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Review of physiology/pathophysiology -- 2. Methods for assessing insulin action in humans -- 3. Assessment of insulin secretion -- 4. Measurement of ectopic fat in liver and muscle using magnetic resonance spectroscopy -- 5. Isotopic tracers for the measurement of metabolic flux -- 6. Measuring food intake in clinical drug development -- 7. Measurement of energy expenditure -- 8. Assessment of body composition -- 9. Assessment of cardiovascular safety of new diabetes drugs.
520 $a This book aims to aid the selection of the most appropriate techniques for use in early phase (1 and 2) clinical studies of new drugs for diabetes, obesity, and related cardiometabolic disease. Clinical research methods for assessing the pharmacokinetics and pharmacodynamics of new diabetes drugs, e.g. the euglycaemic clamp technique, have become well-established in proof-of-mechanism studies; however, selection of the best techniques is by no means straightforward. This book will aid the understanding of the need for new pharmacotherapies for type 1 diabetes, type 2 diabetes, and obesity and the molecular targets of drugs currently in development. Emerging technologies including the omics disciplines are considered together with practical and ethical issues of early phase clinical trials in subjects with cardiometabolic disorders. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development will be of interest to biomedical scientists, pharmacologists, academics involved in metabolic research and clinicians practicing in these specialties.
650 0 $a Drug development. $3 581824
650 0 $a Diabetes $x Treatment. $3 644441
650 0 $a Obesity $x Treatment. $3 798717
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Medicine/Public Health, general. $3 668810
650 2 4 $a Internal Medicine. $3 668583
650 2 4 $a Diabetes. $3 582755
650 2 4 $a Metabolic Diseases. $3 593967
650 2 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
700 1 $a Krentz, Andrew J. $3 973617
700 1 $a Heinemann, Lutz. $3 1064469
700 1 $a Hompesch, Marcus. $3 1064470
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-1-4471-4920-0
950 $a Medicine (Springer-11650)